daunorubicin has been researched along with Cardiomyopathies, Primary in 90 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (43.33) | 18.7374 |
| 1990's | 16 (17.78) | 18.2507 |
| 2000's | 24 (26.67) | 29.6817 |
| 2010's | 9 (10.00) | 24.3611 |
| 2020's | 2 (2.22) | 2.80 |
| Authors | Studies |
|---|---|
| Arao, Y; Fujimoto, K; Fukaya, K; Furusawa, K; Haga, T; Hiraiwa, H; Kano, N; Kato, H; Kondo, T; Kuwayama, T; Morimoto, R; Murohara, T; Mutsuga, M; Oishi, H; Okumura, T; Sawamura, A; Shimizu, S; Sugiura, Y; Usui, A; Watanabe, N; Yamaguchi, S; Yokoi, T | 1 |
| Adamcová, M; Holečková, M; Jirkovská, A; Karabanovich, G; Kocúrová-Lengvarská, J; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Roh, J; Šimůnek, T; Štěrba, M; Štěrbová-Kovaříková, P; Váňová, N | 1 |
| Chen, Z; Li, W; Lu, M; Wang, L; Wang, Z; Xia, D; Yin, N; Zhang, Y | 1 |
| Doka, G; Klimas, J; Krenek, P; Marusakova, M; Pivackova, L; Srankova, J; Veteskova, J | 1 |
| Cernecka, H; Doka, G; Klimas, J; Kmecova, J; Krenek, P; Kucerova, D; Kyselovic, J; Nemcekova, V; Ochodnicka-Mackovicova, K; Ochodnicky, P | 1 |
| Adamcova, M; Gersl, V; Jirkovsky, E; Lencova-Popelova, O; Mazurova, Y; Palicka, V; Simko, F; Sterba, M | 1 |
| Brooks, G; Fernández-Del-Palacio, MJ; García-Nicolás, O; Giraldo, A; Moraleda, JM; Seva, J; Talavera, J | 1 |
| Doka, G; Klimas, J; Krenek, P; Kyselovic, J; Mesarosova, L; Pivackova, L; Srankova, J | 1 |
| Adamek, M; Doka, G; Galkova, K; Klimas, J; Krenek, P; Kruzliak, P; La Rocca, G; Malikova, E; Rodrigo, L | 1 |
| Dhall, G; Ettinger, LJ; Kurer, CC; Mahadeo, KM | 1 |
| Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M | 1 |
| Adamcová, M; Bukac, J; Gersl, V; Hrdina, R; Klimtová, I; Machácková, J; Simůnek, T; Vávrová, J | 1 |
| McHowat, J; Sarvazyan, N; Swift, L | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Simůnek, T; Sterba, M | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Pelouch, V; Simůnek, T | 1 |
| Jones, RL; Miles, DW | 1 |
| Benjamin, RS; Ewer, MS; Gabizon, AA; Henderson, C; Martin, FJ; Shapiro, CL | 1 |
| Aizawa, Y; Kamal, FA; Kodama, M; Kunisaki, M; Ma, M; Mito, S; Palaniyandi, S; Prakash, P; Soga, M; Tachikawa, H; Veeraveedu, P; Watanabe, K | 1 |
| Kucerová, D; Kyselovic, J; Mirossay, A; Mirossay, L; Mojzis, J; Mojzisová, G | 1 |
| Arafah, MM; Najjar, TA; Saad, SY | 1 |
| Adamcová, M; Čajnáková, H; Gersl, V; Hrbatová, L; Ponka, P; Popelová, O; Potáčová, A; Šimůnek, T; Sterba, M | 1 |
| Adamcová, M; Geršl, V; Kaiserová, H; Maláková, J; Popelová, O; Potáčová, A; Šimůnek, T; Štěrba, M; Vávrová, J | 1 |
| Adamcová, M; Gersl, V; Guncová, I; Mazurová, Y; Popelová, O; Potácová, A; Simůnek, T; Sterba, M | 1 |
| Becton, D; Chang, MN; Dahl, GV; Massey, GV; O'Brien, MM; Raimondi, SC; Ravindranath, Y; Stine, KC; Taub, JW | 1 |
| Czarnecki, CM | 1 |
| Ahlberg, NE; Isberg, B; Paul, C; Rajs, J; Svahn, U | 1 |
| Ferrans, VJ | 1 |
| Erdmann, H; Hassel, C; Kleeberg, UR; Mergenthaler, G; Richter von Arnauld, HP | 1 |
| Gibbs, CL; Gibson, WR; Kotsanas, G; Woolley, G | 1 |
| Cangir, A; Obama, M; van Eys, J | 1 |
| Crist, W; Dearth, J; Kelly, D; Malluh, A; Mantle, J; Osborn, R; Rogers, E; Wilson, E | 1 |
| Nepomniashchikh, LM; Semenov, DE; Tsellarius, IuG; Tumanov, VP | 1 |
| Nepomniashchikh, LM; Semenov, DE; Semenova, LA; Tsellarius, IuG | 1 |
| Di Marco, A; Lambertenghi-Deliliers, G; Nava, M; Pozzoli, EF; Praga, C; Soligo, DA; Zanon, PL | 1 |
| Golik, A; Kaufman, S; Reif, R; Yona, R | 1 |
| Bozzio, A; Favrot, MC; Philip, T; Philippe, N; Pouyau, G; Souillet, G | 1 |
| Deprez-DeCampeneere, D; Jaenke, R; Trouet, A | 1 |
| Piccart, M; Rozencweig, M; Von Hoff, DD | 1 |
| Fischer, VW; LaRose, LS; Wang, GM | 1 |
| Asselain, B; Fermont, L; Maynier, M; Zucker, JM | 1 |
| Borgers, M | 1 |
| Lightbody, IM | 1 |
| Barhamand, B | 1 |
| Bors, V; Dorent, R; Gandjbakhch, I; Ghoussoub, JJ; Nataf, P; Pavie, A; Tedy, G; Vaissier, E | 1 |
| Agretto, A; Auricchio, U; Casale, F; Giuliano, M; Iacono, A; Iarussi, D; Indolfi, P; Murano, A | 1 |
| Aichhorn, G; Grillenberger, A; Hofstadler, G; Merl, M; Schmitt, K; Tulzer, G; Wiesinger, G | 1 |
| Gersl, V; Hrdina, R | 1 |
| Andreeva, LI; Khavinson, VKh | 1 |
| Bajgar, J; Gersl, V; Hrdina, R; Krs, O; Mazurová, Y; Palicka, V | 1 |
| Cusack, BJ; Olson, RD; Vestal, RE; Young, SP | 1 |
| Ishikawa, K; Shigeyama, T; Shimoyama, K; Suzuki, J; Tsubota, J; Yanagisawa, A; Yasumura, T | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Kokstein, Z; Mazurová, Y; Melka, M; Palicka, V; Vávrová, J | 1 |
| Balduzzi, A; Galli, MA; Longoni, D; Nicolini, B; Tagliabue, A; Uderzo, C | 1 |
| Bajgar, J; Cerman, J; Gersl, V; Hrdina, R; Machácková, J; Mazurová, Y; Suba, P | 1 |
| Bauer, FK; Burke, BE; Cusack, BJ; Gambliel, H; Olson, RD | 1 |
| Lushnikova, EL; Nepomnyashchikh, LM; Semenov, DE | 7 |
| Albanese, C; Arrigoni, C; Capolongo, L; Caruso, M; Ciomei, M; Della Torre, P; Fiorentini, F; Geroni, C; Lamparelli, MG; Marchini, S; Moneta, D; Ripamonti, M; Rossi, R | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Machácková, J; Mazurová, Y; Mĕlka, M; Nobilis, M | 1 |
| Balazs, T; Ferrans, VJ | 1 |
| Bourut, C; Dantchev, D; Hayat, M; Mathe, G; Paintrand, M; Slioussartchouk, V | 1 |
| Bachmann, E; Holderegger, C; Zbinden, G | 1 |
| Adolfsson, J; Lagerlöf, B; Lantz, B; Reizenstein, P | 1 |
| Benoit, P; Fontaliran, F; Gay, J; Gerbaux, A; Montely, JM | 1 |
| Billingham, ME; Bristow, MR; Daniels, JR; Mason, JW | 1 |
| Mir, MA | 1 |
| Ichimaru, M; Takahara, O; Toyota, S; Yamaguchi, H | 1 |
| Harrison, DT; Sanders, LA | 1 |
| Buja, LM; Ferrans, VJ; Maron, BJ | 1 |
| Jaenke, RS | 1 |
| Azuno, Y; Hiroshige, Y; Nishimura, M; Nishimura, Y; Okafuji, K; Seguchi, M; Tanaka, H; Tanaka, M; Ueda, K; Yoshida, T | 1 |
| Schott, G | 1 |
| Ferrans, VJ; Herman, EH | 2 |
| Durie, EL; Pessah, IN; Schiedt, MJ; Zimanyi, I | 1 |
| Appelt, M; Büchner, T; Eichelbaum, M; Grille, W; Hiddemann, W; Hossfeld, DK; Koslowski, B; Kraft, J; Kuse, R; Quabeck, K | 1 |
| Fischer, VW; Hobart, NH; Wang, GM | 1 |
| Benson, LN; Chan, H; Langevin, A; Souza, MD; Stein, JI; Wilson, G | 1 |
| Clagett-Carr, K; Leyland-Jones, B; Russo, M; Sarosy, G; Weiss, RB | 1 |
| Kadomoto, Y; Kajihara, H; Tahara, E; Yamahara, M; Yokozaki, H | 1 |
| Biron, P; Bouffet, E; Brunat-Mentigny, M; Favrot, MC; Philip, T; Pinkerton, R | 1 |
| Nepomniashchikh, LM; Semenov, DE; Semenova, LA | 1 |
| Gibbs, CL; Gibson, WR; Kotsanas, G | 1 |
| Buja, LM; Ferrans, VJ; Roberts, WC | 1 |
| Aubert, C; Begon, F; Blache, R | 1 |
8 review(s) available for daunorubicin and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Cardiac safety of liposomal anthracyclines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotonic Agents; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Heart; Humans; Liposomes | 2004 |
Animal models of drug-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Doxorubicin; Electrocardiography; Ethanol; Furazolidone; Species Specificity | 1984 |
Anthracycline cardiotoxicity.
Topics: Acute Disease; Animals; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Cardiomyopathies; Chronic Disease; Daunorubicin; Dogs; Doxorubicin; Heart; Heart Failure; Humans; Mice; Naphthacenes; Organ Size; Pericarditis; Rabbits; Rats; Swine | 1983 |
Cardiac lesions induced by chemicals.
Topics: Acute Disease; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Cardiomyopathies; Cardiovascular System; Chronic Disease; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Heart Diseases; Humans; Species Specificity | 1978 |
Model systems for cardiotoxic effects of anthracyclines.
Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Electrocardiography; Female; Rats; Rats, Inbred Strains; Rodent Diseases | 1978 |
Myofibrillar abnormalities following cardiac muscle cell injury.
Topics: Cardiomyopathies; Coronary Disease; Daunorubicin; Doxorubicin; Female; Heart Diseases; Humans; Male; Myocardial Infarction; Myocardium; Myofibrils; Necrosis | 1975 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
Drug-induced cardiomyopathies.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cardiomyopathies; Child; Child, Preschool; Chronic Disease; Cobalt; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Heart; Heart Ventricles; Humans; Hypersensitivity; Male; Microscopy, Electron; Middle Aged; Myocardium | 1974 |
3 trial(s) available for daunorubicin and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child; Coenzymes; Daunorubicin; Echocardiography; Humans; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Treatment Outcome; Ubiquinone; Ventricular Function, Left | 1994 |
Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cytarabine; Daunorubicin; Hemodynamics; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Thioguanine; Verapamil | 1990 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
80 other study(ies) available for daunorubicin and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Daunorubicin; Device Removal; Disease Progression; Female; Fibrosis; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myocardium; Time Factors; Ventricular Function, Left | 2020 |
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Chronic Disease; Daunorubicin; Diketopiperazines; Disease Models, Animal; DNA Damage; Fibrosis; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Prodrugs; Rabbits; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Puerarin attenuates the daunorubicin-induced apoptosis of H9c2 cells by activating the PI3K/Akt signaling pathway via the inhibition of Ca2+ influx.
Topics: Animals; Apoptosis; Calcium Signaling; Cardiomyopathies; Cardiotonic Agents; Daunorubicin; Flow Cytometry; Humans; Isoflavones; Myocytes, Cardiac; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction | 2017 |
Pegfilgrastim and linagliptin potentiate chemoattraction of Ccr2 and Cd44 stem cells accompanied by alterations of cardiac Hgf, Igf-1 and Mcp-1 in daunorubicin cardiomyopathy.
Topics: Animals; Biomarkers; Cardiomyopathies; Cell Movement; Chemokine CCL2; Cytokines; Daunorubicin; Filgrastim; Heart; Hepatocyte Growth Factor; Hyaluronan Receptors; Insulin-Like Growth Factor I; Kaplan-Meier Estimate; Linagliptin; Male; Myocardium; Oxidative Stress; Polyethylene Glycols; Rats; Rats, Wistar; Receptors, CCR2; Stem Cells | 2019 |
Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Enalaprilat; Gene Expression Regulation; Heart; Hemodynamics; PPAR delta; PPAR-beta; Rats; Rats, Wistar | 2013 |
Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Cardiotoxicity; Daunorubicin; Disease Models, Animal; Echocardiography; Heart; Male; Predictive Value of Tests; Rabbits; Regression Analysis; Systole; Troponin I; Troponin T | 2015 |
An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy.
Topics: Animals; Anthracyclines; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Doxorubicin; Echocardiography; Heart Failure; Humans; Myocardium; Rabbits | 2015 |
Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy.
Topics: Acute Disease; Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Cell Movement; Cytokines; Daunorubicin; Disease Models, Animal; Down-Regulation; Heart Ventricles; Insulin-Like Growth Factor I; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells; Ventricular Function, Left | 2016 |
Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Down-Regulation; Male; MicroRNAs; Muscle Proteins; Rats; Rats, Wistar | 2017 |
Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.
Topics: Adolescent; Antibiotics, Antineoplastic; Cardiomyopathies; Chronic Disease; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Natriuretic Peptide, Brain; Tretinoin | 2010 |
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling | 2010 |
Troponins in experimental studies.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Daunorubicin; Heart; Male; Protective Agents; Rabbits; Razoxane; Troponin T | 2002 |
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathies; Cells, Cultured; Daunorubicin; Doxorubicin; Epirubicin; Group VI Phospholipases A2; Heart Ventricles; Idarubicin; Myocytes, Cardiac; Oxidative Stress; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley | 2003 |
Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Chinchilla; Daunorubicin; Male; Myocardial Contraction; Myocardium; Rabbits; Troponin T; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Protein profiling in daunorubicin-induced cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotonic Agents; Daunorubicin; Heart Ventricles; Male; Proteins; Rabbits; Razoxane | 2003 |
Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Biopsy; Cardiomyopathies; Daunorubicin; Doxorubicin; Electrocardiography; Humans; Myocardium | 2005 |
Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Calcium-Transporting ATPases; Cardiomyopathies; Cytoprotection; Daunorubicin; Disease Models, Animal; Electrocardiography; Fas Ligand Protein; Male; Membrane Glycoproteins; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Survival Rate; Tetrazoles; Tumor Necrosis Factors | 2006 |
Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cardiomyopathies; Daunorubicin; Flavonoids; Heart Atria; In Vitro Techniques; Myocytes, Cardiac; Quercetin; Rats; Rats, Wistar | 2006 |
Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Aspartate Aminotransferases; Azoles; Cardiomyopathies; Cardiotonic Agents; Creatine Kinase, MB Form; Daunorubicin; Glutathione; Glutathione Peroxidase; Injections, Subcutaneous; Isoindoles; L-Lactate Dehydrogenase; Male; Myocardium; Nitrates; Nitrites; Organoselenium Compounds; Rats; Rats, Wistar | 2006 |
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Heart Conduction System; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Pyridoxal; Rabbits; Razoxane; Time Factors; Troponin T | 2007 |
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.
Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Biomarkers; Blotting, Western; Cardiomyopathies; Cell Survival; Cells, Cultured; Daunorubicin; Male; Myocytes, Cardiac; Rabbits; Rats; Troponin I; Troponin T | 2007 |
A pilot study of matrix metalloproteinases on the model of daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Cardiomyopathies; Collagen; Daunorubicin; Matrix Metalloproteinases; Rabbits; Troponin T; Ventricular Remodeling | 2007 |
Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child, Preschool; Daunorubicin; Disease-Free Survival; Down Syndrome; Female; Heart; Humans; Leukemia, Myeloid; Male; Mitoxantrone; Prospective Studies; Remission Induction; Retrospective Studies; Treatment Outcome | 2008 |
Myocardial accumulation of 99Tcm-pyrophosphate and 99Tcm-gluconate compared with morphologic findings in daunorubicin treated rabbits.
Topics: Animals; Cardiomyopathies; Daunorubicin; Diphosphates; Drug Administration Schedule; Female; Gluconates; Heart; Male; Myocardium; Organ Size; Organotechnetium Compounds; Rabbits; Radionuclide Imaging; Technetium; Technetium Tc 99m Pyrophosphate | 1982 |
[Monitoring of heart function in the treatment with cardiotoxic cytostatic drugs].
Topics: Cardiomyopathies; Daunorubicin; Doxorubicin; Echocardiography; Electrocardiography; Heart Function Tests; Hemodynamics; Humans | 1984 |
Cardiac energetics in daunorubicin-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Daunorubicin; Energy Metabolism; Heart Failure; Heart Function Tests; Hot Temperature; Oxygen Consumption; Papillary Muscles; Rabbits; Stress, Mechanical | 1984 |
Nutritional status and anthracycline cardiotoxicity in children.
Topics: Antibiotics, Antineoplastic; Body Height; Body Weight; Cardiomyopathies; Child; Daunorubicin; Doxorubicin; Electrocardiography; Humans; Naphthacenes; Nutrition Disorders; Retrospective Studies | 1983 |
Anthracycline-induced cardiomyopathy in children: a report of six cases.
Topics: Adolescent; Antibiotics, Antineoplastic; Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Male; Myocardium; Naphthacenes; Retrospective Studies | 1984 |
[Stereological analysis of myocardial structures in plastic heart insufficiency].
Topics: Animals; Cardiomyopathies; Daunorubicin; Male; Myocardium; Rats; Rats, Inbred Strains | 1983 |
[The phenomenon of cardiomyocyte disappearance in plastic insufficiency of the myocardium].
Topics: Animals; Cardiomyopathies; Daunorubicin; Male; Microscopy, Electron; Muscle Proteins; Myocardium; Organ Size; Rats; Rats, Inbred Strains | 1984 |
Selective mitochondrial alterations induced by a single dose of daunorubicin or 4-demethoxydaunorubicin in mouse ventricular myocardium.
Topics: Animals; Cardiomyopathies; Daunorubicin; Endoplasmic Reticulum; Heart; Idarubicin; Male; Mice; Microscopy, Electron; Mitochondria, Heart; Myocardium | 1980 |
[Cardiac toxicity due to daunomycin].
Topics: Adult; Cardiomyopathies; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute | 1980 |
[Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
Topics: Adolescent; Antibiotics, Antineoplastic; Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Heart Diseases; Humans; Naphthacenes | 1981 |
Comparative cardiac and renal toxicity of daunorubicin in the rat and rabbit.
Topics: Animals; Cardiomyopathies; Daunorubicin; Kidney Diseases; Male; Rabbits; Rats; Rats, Inbred Strains | 1982 |
The cardiotoxicity of anticancer agents.
Topics: Antineoplastic Agents; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Heart; Heart Diseases; Heart Failure; Humans; Neoplasms | 1982 |
Mitigating effects of ICRF-159 (razoxane) on a daunomycin-induced cardiomyopathy in mice.
Topics: Animals; Cardiomyopathies; Daunorubicin; Mice; Myocardium; Piperazines; Razoxane | 1982 |
[Toxic myocardiopathies in pediatrics (author's transl)].
Topics: Adolescent; Antineoplastic Agents; Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Doxorubicin; Echocardiography; Humans; Infant | 1981 |
The role of calcium in the toxicity of the myocardium.
Topics: Acute Disease; Animals; Calcium; Cardiomyopathies; Chronic Disease; Coronary Disease; Daunorubicin; Dogs; Doxorubicin; Heart; Humans; Isoproterenol; Microscopy, Electron; Mitochondria, Heart; Myocardium | 1981 |
Cardiovascular side effects of non-cardiovascular drugs.
Topics: Aged; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Cardiomyopathies; Daunorubicin; Hemodynamics; Humans; Hypertension; Lithium; Phenothiazines; Sympathomimetics; Water-Electrolyte Imbalance | 1980 |
Practice alert: FDA approves Zinecard.
Topics: Breast Neoplasms; Cardiomyopathies; Chelating Agents; Daunorubicin; Doxorubicin; Female; Humans; United States; United States Food and Drug Administration | 1995 |
Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy.
Topics: Actuarial Analysis; Adult; Azathioprine; Cardiomyopathies; Cyclosporine; Daunorubicin; Doxorubicin; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Neoplasms; Prednisolone; Survival Rate | 1995 |
Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: diastolic versus systolic parameters.
Topics: Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Diastole; Doxorubicin; Echocardiography, Doppler; Heart Rate; Hemodynamics; Humans; Prospective Studies; Systole; Ventricular Function, Left | 1995 |
Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Cardiomyopathies; Daunorubicin; Electrocardiography; Male; Myocardial Contraction; Phonocardiography; Rabbits; Stroke Volume; Ventricular Function, Left | 1994 |
[Rubomycin-induced cardiomyopathy in rats and the potential for therapy with a peptide preparation from the heart].
Topics: Animals; Cardiomyopathies; Daunorubicin; Drug Evaluation, Preclinical; Heart; Male; Myocardial Contraction; Myocardium; Peptides; Rats; Time Factors | 1993 |
Changes in cholinesterase activities after daunorubicin administration to rabbits.
Topics: Acetylcholinesterase; Animals; Antibiotics, Antineoplastic; Body Weight; Butyrylcholinesterase; Cardiomyopathies; Daunorubicin; Heart Ventricles; Liver; Male; Myocardium; Rabbits; Tissue Preservation | 1996 |
Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Area Under Curve; Cardiomyopathies; Daunorubicin; Half-Life; Injections, Intravenous; Male; Rats; Rats, Inbred F344 | 1997 |
Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography.
Topics: Adult; Aged; Aged, 80 and over; Angiocardiography; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Doxorubicin; Echocardiography; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Radionuclide Angiography; Ventricular Function, Left | 1999 |
Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Daunorubicin; Drug Administration Schedule; Ethanolamines; Infusions, Intravenous; Isoquinolines; Male; Myocardium; Rabbits; Troponin T | 1999 |
Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
Topics: Acute Disease; Anthracyclines; Bone Marrow Transplantation; Cardiomyopathies; Child; Cytarabine; Daunorubicin; Electroencephalography; Graft vs Host Disease; Humans; Immunosuppressive Agents; Karnofsky Performance Status; Leukemia, Myeloid; Male; Quality of Life; Transplantation, Homologous | 2000 |
Cholinesterases in dexrazoxane-treated daunorubicin cardiomyopathy in rabbits.
Topics: Acetylcholinesterase; Animals; Antibiotics, Antineoplastic; Body Weight; Butyrylcholinesterase; Cardiomyopathies; Cardiovascular Agents; Daunorubicin; Heart; Male; Myocardium; Rabbits; Razoxane; Ventricular Function, Left | 1999 |
Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Down-Regulation; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; Male; Rats; Rats, Inbred F344; Razoxane; RNA, Messenger; Ryanodine Receptor Calcium Release Channel | 2000 |
Focal degradation of cytoplasmic organelles in cardiomyocytes during regenerative and plastic myocardial insufficiency.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Male; Microscopy, Electron; Myocardium; Necrosis; Organelles; Rats; Rats, Wistar | 2000 |
Ultrastructure of nuclear compartment in cardiomyocytes during regenerative and plastic insufficiency of the myocardium.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cell Nucleus; Daunorubicin; Male; Microscopy, Electron; Myocardium; Rats; Rats, Wistar; Regeneration | 2000 |
Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cell Cycle; Cell Division; Daunorubicin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Growth Inhibitors; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Ultrastructural changes in cardiomyocyte mitochondria during regenerative and plastic insufficiency of the myocardium.
Topics: Animals; Cardiomyopathies; Daunorubicin; Intracellular Membranes; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Swelling; Myocardium; Rats; Rats, Wistar | 2001 |
Ultrastructure of the contractile apparatus in cardiomyocytes during regenerative and plastic insufficiency of the myocardium.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Heart; Male; Microscopy, Electron; Myocardium; Rats; Rats, Wistar | 2001 |
Anthracycline-induced cardiomyopathy is manifested in decreased protein synthesis, impaired intracellular regeneration, and non-necrotic death of cardiomyocytes.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Cardiomyopathies; Cell Death; Cell Nucleolus; Cytoplasm; Daunorubicin; Heart; Male; Myocardium; Myofibrils; Necrosis; Rats; Rats, Wistar; Sarcomeres | 2001 |
Alterative and plastic insufficiency of cardiomyocytes: isoproterenol-induced damage to myocardium during anthracycline cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotonic Agents; Cell Death; Daunorubicin; Isoproterenol; Myocardial Contraction; Myocardium; Rats; Rats, Wistar | 2001 |
Relationships between myocardial parenchyma and stroma: regenerative and plastic insufficiency of cardiomyocytes and development of diffuse cardiosclerosis.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Heart; Male; Myocardium; Rats; Rats, Wistar; Sclerosis | 2001 |
[Plasma levels of troponin T in rabbits after administration of new antineoplastic agents (Oracin and Dimefluron) and daunorubicin].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cardiomyopathies; Daunorubicin; Ethanolamines; Fluorenes; Isoquinolines; Rabbits; Troponin T | 2001 |
[Ultrastructural study of cardiotoxicity and skin alterations in the golden hamster after treatment with 8 different anthracyclines].
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cricetinae; Daunorubicin; Doxorubicin; Mesocricetus; Skin Diseases; Time Factors | 1979 |
Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.
Topics: Adult; Aged; Cardiomyopathies; Daunorubicin; Female; Humans; Leukemia; Lipofuscin; Lymphoma; Male; Middle Aged; Pulmonary Edema | 1979 |
[Myocardiopathy from a new anthracyclic derivative (author's transl)].
Topics: Cardiomyopathies; Daunorubicin; Heart Failure; Humans; Male; Melanoma; Middle Aged; Myocardium; Skin Neoplasms | 1979 |
Clinical spectrum of anthracycline antibiotic cardiotoxicity.
Topics: Adolescent; Aged; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Time Factors | 1978 |
Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia; Cardiomyopathies; Daunorubicin; Echocardiography; Female; Heart Failure; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1978 |
[Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
Topics: Adolescent; Adult; Aged; Cardiomyopathies; Child; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Male; Middle Aged; Myocardium | 1978 |
Letter: Pericarditis in a case of early daunorubicin cardiomyopathy.
Topics: Acute Disease; Adult; Bacteriuria; Cardiomyopathies; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Pericarditis; Pseudomonas Infections | 1976 |
Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
Topics: Animals; Binding Sites; Biological Transport; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Doxorubicin; Electrocardiography; Electrolytes; Female; Male; Mitochondria; Myocardium; Myofibrils; Rabbits; Sarcoplasmic Reticulum | 1976 |
[A successful allogeneic bone marrow transplantation for acute promyelocytic leukemia with anthracycline-induced cardiomyopathy at relapse].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cardiomyopathies; Combined Modality Therapy; Daunorubicin; Female; Hemodynamics; Humans; Leukemia, Promyelocytic, Acute; Recurrence; Transplantation, Homologous | 1992 |
[Systolic time intervals and echocardiography in monitoring adriamycin-treated tumor patients].
Topics: Adult; Aged; Cardiac Output; Cardiomyopathies; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Systole; Ventricular Function, Left | 1991 |
Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathy.
Topics: Animals; Cardiomyopathies; Chronic Disease; Daunorubicin; Male; Myocardium; Myofibrils; Rabbits; Razoxane; Time Factors; Vacuoles | 1990 |
Anthraquinone-sensitized Ca2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy.
Topics: Alkaloids; Animals; Anthraquinones; Binding, Competitive; Caffeine; Calcium; Calcium Channels; Cardiomyopathies; Daunorubicin; Doxorubicin; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Female; Heart; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Structure-Activity Relationship | 1990 |
Mitigation of an anthracycline-induced cardiomyopathy by pretreatment with razoxane: a quantitative morphological assessment.
Topics: Animals; Cardiomyopathies; Daunorubicin; Drug Administration Schedule; Intracellular Membranes; Male; Mice; Microscopy, Electron; Mitochondria, Heart; Myocardium; Piperazines; Razoxane; Sarcoplasmic Reticulum; Time Factors | 1986 |
[Serial determination of anthracycline poisoning in children].
Topics: Biopsy; Cardiac Output; Cardiomyopathies; Child; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Endocardium; Heart Failure; Humans; Myocardium; Neoplasms | 1989 |
Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits.
Topics: Animals; Blood Cell Count; Body Weight; Cardiomyopathies; Daunorubicin; Drug Administration Schedule; Drug Interactions; Hemoglobins; Injections, Intraperitoneal; Injections, Intravenous; Male; Piperazines; Rabbits; Razoxane | 1986 |
Anthracycline induced myocardial damage. An analysis of 16 autopsy cases.
Topics: Aclarubicin; Adult; Aged; Antibiotics, Antineoplastic; Cardiomyopathies; Daunorubicin; Doxorubicin; Female; Humans; Male; Middle Aged; Myocardium; Naphthacenes | 1986 |
[Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Daunorubicin; Doxorubicin; Heart; Heart Diseases; Heart Failure; Humans; Pericarditis | 1987 |
[Morphological manifestations of anthracycline cardiomyopathy in the ventricular myocardium of the rat].
Topics: Animals; Cardiomyopathies; Daunorubicin; Disease Models, Animal; Heart Ventricles; Male; Microscopy, Electron; Microscopy, Polarization; Myocardium; Rats; Rats, Inbred Strains; Time Factors | 1987 |
Daunomycin-induced cardiomyopathy in rabbits: isolated heart and papillary muscle energetics.
Topics: Animals; Body Temperature Regulation; Cardiomyopathies; Coronary Vessels; Daunorubicin; Electrocardiography; Energy Metabolism; Heart; Heart Rate; Oxygen Consumption; Papillary Muscles; Perfusion; Rabbits; Stroke Volume; Thermodynamics; Vascular Resistance | 1986 |
[Enzymatic variations and myocardial lesions in the rabbit after an administration of rubidomycin].
Topics: Age Factors; Animals; Aspartate Aminotransferases; Cardiomyopathies; Creatine Kinase; Daunorubicin; Fatty Liver; Gastrointestinal Hemorrhage; Glomerulonephritis; Heart; Injections, Intravenous; Kidney; Liver; Myocardium; Nephritis; Rabbits; Spleen; Time Factors | 1969 |